FDA approves updated Covid-19 vaccines for dominant XFG variant

The U.S. Food and Drug Administration has approved updated Covid-nineteen vaccines designed to target the dominant XFG variant. Per The Guardian, the approval covers updated shots from Moderna, Novavax-Sanofi, and Pfizer-BioNTech, allowing manufacturers to start shipping doses to doctors and pharmacies. While the vaccines are now cleared for distribution, the report notes that confusion remains regarding insurance coverage.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton